Maria van Hooff

Maria van Hooff is a Researcher in the Department of Gastroenterology & Hepatology at Erasmus University Medical Center in Rotterdam, Netherlands. Her work primarily focuses on primary biliary cholangitis, liver transplantation, and hepatocellular carcinoma with significant contributions to understanding disease epidemiology and treatment outcomes.

Her research interests span several key areas in hepatology:

• Primary Biliary Cirrhosis and its nationwide epidemiology
• Liver transplantation outcomes and immunosuppression protocols
• Hepatocellular carcinoma recurrence prediction using novel biomarkers
• Advanced treatments beyond ursodeoxycholic acid for cholestatic liver diseases
• Prognostic scoring systems like GLOBE for disease progression
• Quality of life metrics in chronic liver disease management

Dr. van Hooff's recent publications demonstrate a strong emphasis on collaborative research, including nationwide cohort studies in the Netherlands and analyses using the European Liver Transplant Registry. Her 2024 review article on PBC treatment approaches has garnered significant attention with 12 citations, highlighting her influence in developing therapeutic guidelines. Her work on PIVKA-II as a predictor for hepatocellular carcinoma recurrence represents innovative approaches to post-transplant monitoring, particularly in challenging low alpha-fetoprotein cases.

Her scientific contributions are regularly featured in high-impact journals including JHEP Reports, European Journal of Internal Medicine, and Cancers, with multiple publications receiving substantial attention on academic platforms and social media.